Liver abscess

肝脓肿
  • 文章类型: Case Reports
    在临床实践中,异物相关并发症很少见,但可能是致命的事件。由于异物引起的胃肠道穿孔引起的肝脓肿更为罕见。我们报告了一例63岁的男子,他因发烧和上腹痛入院。进一步的调查显示,尽管抗生素治疗了数周,但肝脓肿仍未消退。在第二次录取中,增强的计算机断层扫描显示肝脏左叶有多个脓肿,收集中带有线性无线电密集异物。进行开放手术以取出异物。患者术后恢复满意,无并发症,术后第六天出院。
    Foreign body-related complications are rare but possibly fatal events in clinical practice. Liver abscess as a result of gastrointestinal perforation caused by foreign bodies is even more rare. We report a case of a 63-year-old man who was admitted with fever and left epigastric pain. Further investigation revealed a liver abscess without resolution despite antibiotic therapy for several weeks. In the second admission, an enhanced computerized tomography scan revealed multiple abscesses in the left lobe of the liver, with a linear radio-dense foreign body within the collection. Open surgery was performed to extract the foreign body. The patient made a satisfactory postoperative recovery without complications and was discharged on the sixth postoperative day.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    肝脓肿是一种潜在的危及生命的医疗紧急情况。有或没有经皮抽吸或引流的经验性抗菌药物是治疗性的。预先使用经验性静脉内广谱抗生素代替口服氟喹诺酮或头孢菌素的合理性存在争议。在这项双盲随机对照临床试验中,69名参与者接受环丙沙星(每12小时500mg),71名参与者口服头孢克肟(每12小时200mg),为期2周。两组均口服甲硝唑(每8小时800mg)2周,并根据适应症进行经皮引流或脓肿抽吸,并随访8周。在140名参与者中,89.3%(N=125)达到临床治愈,环丙沙星组59例(85.5%),头孢克肟组66例(93%)(p=0.154)。抗菌治疗的平均持续时间为16.2±4.3天,环丙沙星组15.1±4.5天,头孢克肟组16.0±4.2天(p=0.223)。共有15名(10.7%)参与者治疗失败,环丙沙星组10例(14.5%),头孢克肟组5例(7.0%)(p=0.154)。治疗失败的最常见原因是需要延长(>4周)抗菌治疗,由于持续的肝收集需要引流,环丙沙星(14.5%,N=10)组,与头孢克肟(4.2%,N=3)组。总之,两者,持续2~3周的环丙沙星或头孢克肟联合甲硝唑作为经验性口服抗菌方案以及及时经皮引流或抽吸治疗单纯性肝脓肿的疗效相似.口服头孢克肟优于环丙沙星,由于持续收集,治疗失败的机会较小,需要在更大的临床试验中进一步研究。试用注册:clinicaltrials.govPRSID:NCT03969758,2019年5月31日。
    Liver abscess is a potentially life-threatening medical emergency. Prompt empirical antimicrobial with or without percutaneous aspiration or drainage is therapeutic. The rational for using empirical intravenous broad-spectrum antimicrobials upfront instead of oral Fluoroquinolone or Cephalosporin is contentious. In this double blind randomized control clinical trial 69 participants received Ciprofloxacin (500 mg q 12 hourly) and 71 participants received Cefixime (200 mg q 12 hourly) orally for 2 weeks. Both the group received oral Metronidazole (800 mg q 8 hourly) for 2 weeks and percutaneous drainage or aspiration of the abscess was done as per indication and followed-up for 8 weeks. Out of 140 participants, 89.3% (N = 125) achieved clinical cure, 59 (85.5%) in Ciprofloxacin group and 66 (93%) in Cefixime group (p = 0.154). Mean duration of antimicrobial therapy was 16.2 ± 4.3 days, 15.1 ± 4.5 days in Ciprofloxacin group and 16.0 ± 4.2 days in Cefixime group (p = 0.223). Total 15 (10.7%) participants had treatment failure, 10 (14.5%) in Ciprofloxacin group and 5 (7.0%) in Cefixime group (p = 0.154). The most common reason for treatment failure was need of prolong (> 4 weeks) antimicrobial therapy due to persistent hepatic collection requiring drainage, which was significantly (p = 0.036) higher in Ciprofloxacin (14.5%, N = 10) group, compared to the Cefixime (4.2%, N = 3) group. In conclusion, both, the Ciprofloxacin or Cefixime plus Metronidazole for duration of 2-3 weeks were efficacious as empirical oral antimicrobial regimen along with prompt percutaneous drainage or aspiration for the treatment of uncomplicated liver abscess with similar efficacy. Oral Cefixime was better than Ciprofloxacin in term of lesser chance of treatment failure due to persistent collection which is required to be investigated further in larger clinical trial.Trial registration: clinicaltrials.gov PRS ID: NCT03969758, 31/05/2019.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    在急诊(ED)败血症患者中早期识别感染源仍然具有挑战性。计算机断层扫描(CT)具有识别感染源的潜力。这项回顾性研究旨在探讨CT在确定无明显感染灶的脓毒症患者感染来源中的作用。对2020年7月1日至2021年6月30日期间访问林口长庚纪念医院ED的发烧和败血症患者进行了回顾性图表审查。患者人口统计数据,生命体征,临床症状,潜在的医疗状况,实验室结果,管理干预措施,住院时间,收集和分析死亡率结局.在纳入研究的218名患者中,139例(63.8%)的CT表现为阳性。CT发现的最常见感染源包括肝脓肿,急性肾盂肾炎,和胆管炎.实验室结果显示,CT表现阳性的患者白细胞和绝对中性粒细胞计数较高,血红蛋白水平较低。血培养结果阳性多见于CT表现阳性的患者。此外,CT发现阳性组的住院时间更长.多因素logistic回归分析显示,血红蛋白水平和血培养结果阳性可独立预测无明显感染源的发热或脓毒症患者的CT表现。在感染病灶未确定的脓毒症患者中,那些出现白细胞增多的人,贫血,和绝对中性粒细胞计数升高倾向于在腹部CT扫描中具有阳性结果。这些患者的菌血症发生率很高,住院时间更长。腹部CT仍然是一种有价值的诊断工具,可用于在精心选择的未确定感染起源的败血症患者中识别感染源。
    Early identification of the sources of infection in emergency department (ED) patients of sepsis remains challenging. Computed tomography (CT) has the potential to identify sources of infection. This retrospective study aimed to investigate the role of CT in identifying sources of infection in patients with sepsis without obvious infection foci in the ED. A retrospective chart review was conducted on patients with fever and sepsis visiting the ED of Linkou Chang Gung Memorial Hospital between July 1, 2020 and June 30, 2021. Data on patient demographics, vital signs, clinical symptoms, underlying medical conditions, laboratory results, administered interventions, length of hospital stay, and mortality outcomes were collected and analyzed. Of 218 patients included in the study, 139 (63.8%) had positive CT findings. The most common sources of infection detected by CT included liver abscesses, acute pyelonephritis, and cholangitis. Laboratory results showed that patients with positive CT findings had higher white blood cell and absolute neutrophil counts and lower hemoglobin levels. Positive blood culture results were more common in patients with positive CT findings. Additionally, the length of hospital stay was longer in the group with positive CT findings. Multivariate logistic regression analysis revealed that hemoglobin levels and positive blood culture results independently predicted positive CT findings in patients with fever or sepsis without an obvious source of infection. In patients with sepsis with an undetermined infection focus, those presenting with leukocytosis, anemia, and elevated absolute neutrophil counts tended to have positive findings on abdominal CT scans. These patients had high rates of bacteremia and longer lengths of stay. Abdominal CT remains a valuable diagnostic tool for identifying infection sources in carefully selected patients with sepsis of undetermined infection origins.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    血小板减少症通常与感染性疾病相关,并可作为疾病严重程度的指标。然而,关于其与肺炎克雷伯菌肝脓肿(KPLA)一起表现的报道很少。本研究旨在阐明血小板减少症与KPLA严重程度之间的相关性,并深入研究导致血小板减少症发生率的病因。
    对2012年6月至2023年6月收治的KPLA患者的临床数据进行了回顾性分析。基线特征,生化评估,治疗性干预措施,并发症,比较有和无血小板减少症患者的临床结局.为了调查潜在的血小板减少症的病因,检查了血小板计数减少与血栓性静脉炎之间的关联,特别关注血小板消耗。此外,评估骨髓穿刺结果以评估血小板生成异常.
    总共361名KPLA患者被纳入研究,其中60人(17%)并发血小板减少症.血小板减少组的血栓性静脉炎发生率明显增高(p=0.042),肝外转移感染(p=0.01),感染性休克(p=0.024),重症监护室入院(p=0.002),和住院死亡率(p=0.045)。多因素分析显示血小板减少(比值比,2.125;95%置信区间,1.114-4.056;p=0.022)与血栓性静脉炎独立相关。在血小板减少症患者中,八人接受了骨髓穿刺,和6(75%)有髓血小板产生受损。治疗后,88.6%的血小板减少症患者(n=47)显示血小板计数恢复,中位恢复时间为5天(四分位距,3-6天)。
    KPLA患者的血小板减少表明疾病严重程度增加。血小板减少症的潜在病因可能包括骨髓内血小板产生受损和外周血小板消耗增加,如血栓性静脉炎的存在所证明。
    UNASSIGNED: Thrombocytopenia is commonly associated with infectious diseases and serves as an indicator of disease severity. However, reports on its manifestation in conjunction with Klebsiella pneumoniae liver abscess (KPLA) are scarce. The present study sought to elucidate the correlation between thrombocytopenia and KPLA severity and delve into the etiological factors contributing to the incidence of thrombocytopenia.
    UNASSIGNED: A retrospective analysis of the clinical data from patients with KPLA admitted between June 2012 and June 2023 was performed. Baseline characteristics, biochemical assessments, therapeutic interventions, complications, and clinical outcomes were compared between patients with and without thrombocytopenia. To investigate the potential etiologies underlying thrombocytopenia, the association between platelet count reduction and thrombophlebitis was examined, with a particular focus on platelet consumption. Furthermore, bone marrow aspiration results were evaluated to assess platelet production anomalies.
    UNASSIGNED: A total of 361 KPLA patients were included in the study, among whom 60 (17%) had concurrent thrombocytopenia. Those in the thrombocytopenia group exhibited significantly higher rates of thrombophlebitis (p = 0.042), extrahepatic metastatic infection (p = 0.01), septic shock (p = 0.024), admissions to the intensive care unit (p = 0.002), and in-hospital mortality (p = 0.045). Multivariate analysis revealed that thrombocytopenia (odds ratio, 2.125; 95% confidence interval, 1.114-4.056; p = 0.022) was independently associated with thrombophlebitis. Among the thrombocytopenic patients, eight underwent bone marrow aspiration, and six (75%) had impaired medullar platelet production. After treatment, 88.6% of thrombocytopenic patients (n = 47) demonstrated recovery in their platelet counts with a median recovery time of five days (interquartile range, 3-6 days).
    UNASSIGNED: Thrombocytopenia in patients with KPLA is indicative of increased disease severity. The underlying etiologies for thrombocytopenia may include impaired platelet production within the bone marrow and augmented peripheral platelet consumption as evidenced by the presence of thrombophlebitis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:肝脓肿,特别是化脓性和变形虫类型,构成重大的医疗保健挑战,尤其是在发展中国家。这些脓肿类型的准确区分和有效治疗在急诊医疗环境中至关重要。本研究旨在分析发病率,临床特征,创伤和急诊科化脓性和阿米巴性肝脓肿的治疗结果。
    方法:在英迪拉·甘地医学科学研究所(IGIMS)进行,巴特那,这项为期一年的观察性研究纳入了100例诊断为肝脓肿的患者.这项研究采用了全面的方法,检查发病率,人口趋势,临床表现,治疗方式,和结果,包括复发率。
    结果:该研究观察到化脓性肝脓肿的发生率更高,占病例的60%(n=60),与阿米巴肝脓肿相比,占40%(n=40)。就人口统计而言,化脓性肝脓肿在老年男性中更为普遍,平均年龄48岁,70%(n=42)的患者为男性。相比之下,阿米巴肝脓肿患者平均年龄42岁,60%(n=24)是男性。主要临床发现显示,化脓性肝脓肿病例(n=60)的白细胞计数和肝酶水平高于阿米巴肝脓肿(n=40)。治疗结果表明两种类型的肝脓肿的成功率都很高。化脓性肝脓肿的成功率为90%(n=54),而阿米巴肝脓肿的成功率略高,为95%(n=38)。然而,复发率有显著差异:化脓性肝脓肿复发率为8.3%(n=5),而阿米巴肝脓肿的复发率较低,为2.5%(n=1)。为确定治疗成功的潜在预测因素而进行的逻辑回归分析未揭示两种类型的肝脓肿的任何统计学显着因素。
    结论:该研究强调了印度城市医疗保健环境中化脓性肝脓肿的发病率较高,以及根据人口统计学和临床因素预测治疗结果的复杂性。研究结果强调需要细致入微的临床方法和警惕的治疗后监测,尤其是化脓性肝脓肿。他们还强调了进一步研究以探索影响肝脓肿治疗结果的其他变量的重要性。
    BACKGROUND: Liver abscesses, particularly pyogenic and amoebic types, pose a significant healthcare challenge, especially in developing countries. Accurate differentiation and effective treatment of these abscess types are crucial in emergency medical settings. This study aims to analyze the incidence, clinical characteristics, and treatment outcomes of pyogenic and amoebic liver abscesses in a trauma and emergency department setting.
    METHODS: Conducted at the Indira Gandhi Institute of Medical Sciences (IGIMS), Patna, this one-year observational study involved 100 patients diagnosed with liver abscesses. The study employed a comprehensive approach, examining incidence rates, demographic trends, clinical presentations, treatment modalities, and outcomes, including recurrence rates.
    RESULTS: The study observed a higher incidence of pyogenic liver abscesses, accounting for 60% of cases (n=60), compared to amoebic liver abscesses, which constituted 40% (n=40). In terms of demographics, pyogenic liver abscesses were more prevalent among older males, with the average age being 48 years, and 70% (n=42) of the patients were male. In contrast, amoebic liver abscess patients had an average age of 42 years, with 60% (n=24) being male. Key clinical findings revealed that pyogenic liver abscess cases (n=60) had higher white blood cell counts and elevated liver enzyme levels than those with amoebic liver abscesses (n=40). The treatment outcomes indicated high success rates for both types of liver abscesses. Pyogenic liver abscesses had a success rate of 90% (n=54), while amoebic liver abscesses showed a slightly higher success rate at 95% (n=38). However, there was a notable difference in recurrence rates: pyogenic liver abscesses had a recurrence rate of 8.3% (n=5), whereas amoebic liver abscesses had a lower recurrence rate of 2.5% (n=1). The logistic regression analysis conducted to identify potential predictors of treatment success did not reveal any statistically significant factors across both types of liver abscesses.
    CONCLUSIONS: The study highlights a higher incidence of pyogenic liver abscesses in an urban Indian healthcare setting and the complexity of predicting treatment outcomes based on demographic and clinical factors. The findings emphasize the need for nuanced clinical approaches and vigilant post-treatment monitoring, especially for pyogenic liver abscesses. They also underscore the importance of further research to explore additional variables influencing liver abscess treatment outcomes.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Multicenter Study
    目的:为了研究临床发现,治疗策略,以及证实有肝脓肿的狗的结果。
    方法:2010-2019年回顾性队列研究。
    方法:多中心研究。
    方法:通过培养证实有肝脓肿的56只客户饲养的狗,细胞学,或组织病理学。
    结果:狗出现嗜睡(39/56),缺氧(31/56),呕吐(26/56)。异常体格检查结果包括体温升高(41/56)和腹痛(22/54)。CBCs显示中性粒细胞增多(31/49),毒性变化(25/49),贫血(28/49),和血小板减少症(23/49)。生化分析显示碱性磷酸酶增加(45/50),丙氨酸转氨酶增加(40/50),低蛋白血症(25/48),和高胆红素血症(19/49)。在49只狗中的13只中发现了低血糖。48只狗中的37只经超声检查发现直径为0.5至15厘米的肝脓肿;37只狗中有19只有单独脓肿,37人中有18人患有多灶性脓肿。大肠杆菌是最常见的培养生物,在42例中的18例中被隔离。组织病理学显示,47只狗中有10只存在潜在的肝肿瘤。49只狗中的41只进行了手术治疗,41人中有35人存活出院。对49只狗中的8只进行了医疗管理,8人中有5人存活出院。通过单变量分析,低血糖和多灶性脓肿与生存率降低相关(分别为比值比[OR]:0.2,95%置信区间[CI]:0.03~0.9,P=0.04;OR:0.07,95%CI:0.01~0.6,P=0.02).通过多变量分析,只有多灶性脓肿与生存率降低相关(OR:0.09,95%CI:0.01-0.87,P=0.04).
    结论:肝脓肿,虽然罕见,对于表现为非特异性临床体征并增加肝酶活性的犬,应保持鉴别诊断,尤其是伴有温度升高和嗜中性粒细胞增多。在这项研究中,狗的存活率与先前报道的存活率一致。总人口的56人中有40人(71%)存活出院。没有评估的变量能够预测出院后的生存率;然而,应在较大人群中评估低血糖和多灶性脓肿,以确定预后意义.
    OBJECTIVE: To investigate the clinical findings, treatment strategies, and outcomes in dogs with confirmed hepatic abscessation.
    METHODS: Retrospective cohort study from 2010 to 2019.
    METHODS: Multicenter study.
    METHODS: Fifty-six client-owned dogs with hepatic abscessation confirmed by culture, cytology, or histopathology.
    RESULTS: Dogs were presented for lethargy (39/56), hyporexia (31/56), and vomiting (26/56). Abnormal physical examination findings included increased temperature (41/56) and abdominal pain (22/54). CBCs revealed neutrophilia (31/49), toxic changes (25/49), anemia (28/49), and thrombocytopenia (23/49). Biochemical analyses revealed increased alkaline phosphatase (45/50), increased alanine aminotransferase (40/50), hypoalbuminemia (25/48), and hyperbilirubinemia (19/49). Hypoglycemia was found in 13 of 49 dogs. Hepatic abscesses ranging from 0.5 to 15 cm in diameter were identified ultrasonographically in 37 of 48 dogs; 19 of 37 had solitary abscesses, and 18 of 37 had multifocal abscessation. Escherichia coli was the most commonly cultured organism, isolated in 18 of 42 cases. Histopathology revealed underlying hepatic neoplasia in 10 of 47 dogs. Surgical management was performed in 41 of 49 dogs, and 35 of 41 survived to discharge. Medical management was performed in 8 of 49 dogs, and 5 of 8 survived to discharge. With univariate analysis, hypoglycemia and multifocal abscessation were associated with decreased odds of survival (odds ratio [OR]: 0.2, 95% confidence interval [CI]: 0.03-0.9, P = 0.04; OR: 0.07, 95% CI: 0.01-0.6, P = 0.02, respectively). With multivariate analysis, only multifocal abscessation was associated with decreased odds of survival (OR: 0.09, 95% CI: 0.01-0.87, P = 0.04).
    CONCLUSIONS: Hepatic abscessation, although rare, should remain a differential diagnosis for dogs presenting with nonspecific clinical signs and increase liver enzyme activities, especially with concurrent increased temperature and neutrophilia. Rate of survival to discharge for dogs in this study was consistent with previously reported survival rates, with 40 of 56 (71%) of the total population surviving to discharge. No variables assessed were able to predict survival to discharge; however, hypoglycemia and multifocal abscessation should be assessed in larger populations to determine prognostic significance.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Randomized Controlled Trial
    目的:小儿肝脓肿的误吸标准尚不清楚。在这项随机对照试验中,我们评估了无并发症肝脓肿患儿除抗生素外,超声引导下针吸活检的疗效.
    方法:我们招募了110名1-18岁(平均[SD]=7.7[3.7]岁)无并发症肝脓肿的儿童。主要结果是6周时的临床治愈(在前14天内没有发烧和腹痛,超声检查显示脓肿大小减小)。次要结果是4周时的临床反应,发烧解决时间,腹部疼痛减轻和腹部压痛的时间,住院时间,治疗失败。
    结果:吸入加抗生素组和仅抗生素组之间在6周时的临床治愈没有显着差异(48/50[96%]对39/46[85%];P=0.082)。4周时的临床反应也相当(49/50[98%]对43/46[93.5%];P=0.347)。吸入加抗生素组发热消退时间的平均值(SD)明显较少(198[90.8]hvs248.2[104.6]h;P=0.014)。减轻腹痛的时间(8.32[3.1]vs9.46[3.1]天;P=0.077)和腹部压痛(5.7[2.4]vs6.3[2.3]天;P=0.242),住院时间(16.6[3.9]对18.2[4.4]天;P=0.07),和不良事件概况(9/50[18%]vs14/46[30%];P=0.217)在两组之间具有可比性.
    结论:大多数无并发症肝脓肿患儿在静脉注射抗生素治疗6周时达到临床治愈,不管渴望。然而,针吸可以稍微减少发热和腹痛/腹部压痛的持续时间。
    OBJECTIVE: The criteria for aspiration for pediatric liver abscess are unclear. In this randomized controlled trial, we evaluated the efficacy of ultrasound-guided needle aspiration in addition to antibiotics in children with uncomplicated liver abscess.
    METHODS: We enrolled 110 children aged 1-18 years (mean [SD] = 7.7 [3.7] years) with uncomplicated liver abscess. The primary outcome was clinical cure at 6 weeks (absence of fever and abdominal pain in the preceding 14 days with reduction in abscess size on ultrasonography). The secondary outcomes were clinical response at 4 weeks, fever resolution time, time to abdominal pain reduction and abdominal tenderness, duration of hospitalization, and treatment failure.
    RESULTS: Clinical cure at 6 weeks was not significantly different (48/50 [96%] vs 39/46 [85%]; P = 0.082) between aspiration plus antibiotics group and antibiotics only group. The clinical response at 4 weeks was also comparable (49/50 [98%] vs 43/46 [93.5%]; P = 0.347). The mean (SD) of fever resolution time was significantly less in the aspiration plus antibiotics group (198 [90.8] h vs 248.2 [104.6] h; P = 0.014). Time to achieve reduction in abdominal pain (8.32 [3.1] vs 9.46 [3.1] days; P = 0.077) and abdominal tenderness (5.7 [2.4] vs 6.3 [2.3] days; P = 0.242), duration of hospitalization (16.6 [3.9] vs 18.2 [4.4] days; P = 0.07), and adverse event profile (9/50 [18%] vs 14/46 [30%]; P = 0.217) were comparable between the two groups.
    CONCLUSIONS: Majority of children with uncomplicated liver abscess achieved clinical cure at 6 weeks with intravenous antibiotics, irrespective of aspiration. However, needle aspiration may slightly reduce the duration of fever and abdominal pain/abdominal tenderness.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    化脓性肝脓肿(PLA)是一种罕见的实体,与大量的死亡率和发病率有关。我们的目的是调查瑞典南部诊断为PLA的患者与死亡率和后续PLA相关的变量。
    我们进行了一项基于人群的观察性研究,包括2011年至2020年在斯科恩县发生的所有PLA事件,瑞典南部主要结局定义为全因90天死亡率,次要结局定义为后续PLA的发生。
    研究期间,360名患者共发生452次PLA发作。90天死亡率为16%(n=58),随后的PLA率为20%(n=92)。在多变量逻辑回归模型中,女性(赔率比[OR],2.0[95%置信区间{CI},1.1-3.9]),恶性肿瘤(OR,3.7[95%CI,1.9-7.1]),肝功能衰竭(OR,6.3[95%CI,2.7-14.5]),和多微生物发现(OR,3.8[95%CI,2.2-6.9])与90天内的死亡相关(P<0.05)。男性(或,2.1[95%CI,1.2-3.6]),恶性肿瘤(OR,2.1[95%CI,1.3-3.6]),年龄(64-74岁:或,2.5[95%CI,1.3-4.8]),和慢性肝病(OR,3.0[95%CI,1.4-6.5])与后续PLA风险相关(P≤0.01)。
    确定与不良结局相关的不同临床变量可以改善PLA患者的管理和治疗,从而预防死亡和后续PLA的风险。
    UNASSIGNED: Pyogenic liver abscess (PLA) is a rare entity that is associated with substantial mortality and morbidity. Our objective was to investigate variables associated with mortality and subsequent PLA in patients diagnosed with PLA in southern Sweden.
    UNASSIGNED: We conducted a population-based observational study comprising all episodes of PLA that occurred between 2011 and 2020 in the county of Skåne, southern Sweden. The primary outcome was defined as all-cause 90-day mortality and the secondary outcome was defined as the occurrence of a subsequent PLA.
    UNASSIGNED: A total of 452 episodes of PLA occurred in 360 patients during the study period. The 90-day mortality rate was 16% (n = 58) and the subsequent PLA rate was 20% (n = 92). In a multivariable logistic regression model, female sex (odds ratio [OR], 2.0 [95% confidence interval {CI}, 1.1-3.9]), malignancy (OR, 3.7 [95% CI, 1.9-7.1]), liver failure (OR, 6.3 [95% CI, 2.7-14.5]), and polymicrobial findings (OR, 3.8 [95% CI, 2.2-6.9]) were associated with death within 90 days (P < .05). Male sex (OR, 2.1 [95% CI, 1.2-3.6]), malignancy (OR, 2.1 [95% CI, 1.3-3.6]), age (64-74 years: OR, 2.5 [95% CI, 1.3-4.8]), and chronic liver disease (OR, 3.0 [95% CI, 1.4-6.5]) were associated with the risk of subsequent PLA (P ≤ .01).
    UNASSIGNED: Identifying different clinical variables associated with an unfavorable outcome may improve the management and treatment of patients with PLA and thus prevent the risk of death and subsequent PLA.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Systematic Review
    目的:比较经皮穿刺置管引流术(PCD)与经皮穿刺活检(PNA)治疗肝脓肿的有效性和安全性。
    方法:系统评价,荟萃分析和试验序贯分析。
    方法:PubMed,WebofScience,科克伦图书馆,Embase,从成立之初到2022年3月16日,搜索了Airiti图书馆和ClinicalTrials.gov。
    方法:比较PCD与PNA治疗肝脓肿的随机对照试验被认为是合格的,语言没有限制。
    方法:主要结果是治疗成功率。根据异质性,固定效应模型或随机效应模型用于得出总体估计值。使用ReviewManagerV.5.3软件进行荟萃分析。使用试验顺序分析软件进行试验顺序分析。使用建议分级来评估证据的确定性,评估,开发和评估系统。
    结果:纳入10项试验,共1287名个体。汇总分析显示PCD,与PNA相比,提高治疗成功率(风险比1.16,95%CI1.07至1.25)。试验顺序分析证明了这一可靠的发现,并获得了所需的信息大小。对于大脓肿,亚组分析有利于PCD(亚组差异检验,p<0.001)。与PNA相比,汇总分析表明,在6项1000名患者的研究中,PCD在达到临床改善或完全缓解(平均差异(MD)-2.53天;95%CI-3.54至-1.52)方面具有显着的益处;在5项772名患者的研究中,脓肿大小减少50%的时间(MD-2.49天;95%CI-3.59至-1.38);静脉内使用抗生素的持续时间(MD-4.04天95%CI-5.99至-2.10)在四项763例患者的研究中。住院死亡率和并发症没有差异。
    结论:在肝脓肿患者中,超声引导下的PCD将1000例患者的治疗成功率提高了136例,将临床结局改善3天,将静脉注射抗生素的需要减少4天.
    CRD4202236540。
    To compare the effectiveness and safety of percutaneous catheter drainage (PCD) against percutaneous needle aspiration (PNA) for liver abscess.
    Systematic review, meta-analysis and trial sequential analysis.
    PubMed, Web of Science, Cochrane Library, Embase, Airiti Library and ClinicalTrials.gov were searched from their inception up to 16 March 2022.
    Randomised controlled trials that compared PCD to PNA for liver abscess were considered eligible, without restriction on language.
    Primary outcome was treatment success rate. Depending on heterogeneity, either a fixed-effects model or a random-effects model was used to derive overall estimates. Review Manager V.5.3 software was used for meta-analysis. Trial sequential analysis was performed using the Trial Sequential Analysis software. Certainty of evidence was evaluated using the Grading of Recommendations, Assessment, Development and Evaluation system.
    Ten trials totalling 1287 individuals were included. Pooled analysis revealed that PCD, when compared with PNA, enhanced treatment success rate (risk ratio 1.16, 95% CI 1.07 to 1.25). Trial sequential analysis demonstrated this robust finding with required information size attained. For large abscesses, subgroup analysis favoured PCD (test of subgroup difference, p<0.001). In comparison to PNA, pooled analysis indicated a significant benefit of PCD on time to achieve clinical improvement or complete clinical relief (mean differences (MD) -2.53 days; 95% CI -3.54 to -1.52) in six studies with 1000 patients; time to achieve a 50% reduction in abscess size (MD -2.49 days; 95% CI -3.59 to -1.38) in five studies with 772 patients; and duration of intravenous antibiotic use (MD -4.04 days, 95% CI -5.99 to -2.10) in four studies with 763 patients. In-hospital mortality and complications were not different.
    In patients with liver abscess, ultrasound-guided PCD raises the treatment success rate by 136 in 1000 patients, improves clinical outcomes by 3 days and reduces the need for intravenous antibiotics by 4 days.
    CRD42022316540.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景技术肝脓肿是自古以来人类已知的疾病,并且已经通过各种手段治疗。放射学引导的介入引流术的引入降低了死亡率,这是管理的重要组成部分。然而,主要在资源有限的发展中国家,在中型肝脓肿的选择方法方面仍然存在两难选择。方法对60例中度(5~10cm)肝脓肿患者进行研究,液化,可引流,随机分为两组,每组30例患者,接受超声引导下的针吸或导管引流,并采用相同的药物治疗。比较两组患者对镇痛药的需求,住院总持续时间,休假和重复或剩余收集的总天数。结果两组患者的年龄具有可比性,性别,脓肿类型和最大直径。成功率相等(80%和84%)。然而,需要镇痛药,与导管引流组相比,针吸组的住院总时间和休假总天数显着减少(p<0.05),平均住院时间为9.3±3.18天,平均休假时间为18.9±5.13天,平均住院时间为14.8±5.95天和32.5±11.4天。结论根据我们的研究结果,我们得出的结论是,经皮穿刺术是中等大小(5-10cm)肝脓肿的主要介入治疗方法。应该进行更多的多中心和随机试验来证实这项研究的推论。
    Background Liver abscess is a disease known to mankind since ancient times and has been treated by various means. The introduction of radiology-guided interventional drainage procedures has reduced the mortality rate, which forms a significant part of management. However, there is still a dilemma regarding the procedure of choice in medium-sized liver abscesses mainly in resource-limited developing countries. Methods The study was conducted on 60 patients with moderate-sized (5-10 cm) liver abscess/abscesses, liquified, drainable and divided randomly into two groups with 30 patients each and subjected to either Ultrasound-guided needle aspiration or catheter drainage with identical medical treatment. Outcomes were compared within both groups concerning the need for analgesics, total duration of hospital stay, total days of leave from work and recurrence or residual collection. Results Both groups were comparable in age, gender, type of abscess and maximal diameter. The success rate was equal (80% and 84%). However, the need for analgesics, total duration of hospital stay and total days of leave from work showed a significant (p<0.05) decrease in the needle aspiration group with a mean stay of 9.3 ± 3.18 days and mean leave of 18.9 ± 5.13 days as compared to catheter drainage group with the mean of 14.8 ±5.95 days and 32.5 ±11.4 days respectively. Conclusion Based on our study\'s results, we conclude that percutaneous needle aspiration is a primary interventional treatment in moderate-sized (5-10 cm) liver abscesses. More multicentric and randomised trials should be done to confirm the inference of this study.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号